Brief: Arbutus Biopharma Corp - EPO Revokes Arbutus Biopharma's European Patent EP 2279254 - SEC Filing
Jan 16 (Reuters) - Arbutus Biopharma Corp ABUS.O: ARBUTUS BIOPHARMA CORP - EPO REVOKES ARBUTUS BIOPHARMA'S EUROPEAN PATENT EP 2279254 - SEC FILING ARBUTUS BIOPHARMA CORP - DECISION LIKELY TO AFFECT ARBUTUS CASE AGAINST MODERNA IN SWITZERLAND - SEC FILING ARBUTUS BIOPHARMA CORP - EXPECTS NO IMPACT ON U.S., JAPAN, CANADA LITIGATION - SEC FILING ARBUTUS BIOPHARMA CORP: CO DISAGREES WITH OUTCOME, PLANS TO FILE PETITION FOR REVIEW BY ENLARGED BOARD OF APPEAL OF EPO Further company coverage: ABUS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Arbutus Biopharma
See all newsU.S. STOCKS ON THE MOVE-Quest Diagnostics, Tractor Supply, Dutch Bros
Arbutus rises after FDA lifts clinical hold for experimental hepatitis B drug
Brief: Arbutus Announces Final Results Of Its Us$230 Million Modified “Dutch Auction” Tender Offer
Brief: Arbutus Announces Preliminary Results Of Its Us$230 Million Modified “Dutch Auction” Tender Offer
U.S. STOCKS ON THE MOVE-Moderna, O-I Glass, Aveanna Healthcare